RxDoctor Payments Data

Barbra Droddy, PA

Physician Assistant · Gulfport, MSNPI 1740533280

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.4% of the total across 272 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 31 manufacturers, the largest accounting for just 13.6% — the pattern of someone who eats at a lot of different presentations. Among physician assistant clinicians in MS with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$5,774in general payments, 2019–2025

Across 272 payments — averaging $21.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$787
  • Sanofi$751
  • Galderma Laboratories, L.p.$684
  • Johnson & Johnson$563
  • Novartis$330
  • UCB, Inc.$319
  • plus $2K from 25 others

What the payments were for

  • Food & beverage$5,45094%
  • Education$3246%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$5,774 in reported general payments places this provider in the 90th percentile of 278 physician assistant providers in Mississippi.

See all physician assistant providers in Mississippi

Medicare billing

Part B allowed, 2024
$169,828
Medicare patients
749
Services billed
8,852

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Dupixent PenDupilumab53$201,165
AdbryTralokinumab-Ldrm13$50,871
Dupixent SyringeDupilumab13$48,238
Ketoconazole102$2,376
Tretinoin19$2,077
Clobetasol Propionate45$1,584
Clindamycin Phosphate29$1,306
Triamcinolone Acetonide126$1,155
Metronidazole15$825
Fluocinonide21$721
Doxycycline Hyclate30$667
Fluconazole22$354
Minoxidil56$296
Mupirocin21$137

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
LEO Pharma Inc.Adbry$109$50,87113 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 278 physician assistant providers in Mississippi.

Other physician assistant in Gulfport

See the full list for Mississippi

Where these figures come from

Is this you, or does something look wrong? →